Form 424B2 - Prospectus [Rule 424(b)(2)]:
SEC Accession No. 0001437749-25-027557
Filing Date
2025-08-22
Accepted
2025-08-22 09:17:19
Documents
4

Document Format Files

Seq Description Document Type Size
1 FORM 424B2 dmtp20250821_424b2.htm 424B2 216903
2 dmtp20250811_s3img006.jpg GRAPHIC 6992
3 logo.jpg GRAPHIC 8193
4 pipeline2.jpg GRAPHIC 31423
  Complete submission text file 0001437749-25-027557.txt   282594
Mailing Address 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305
Business Address 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305 (763) 496-5454
DiaMedica Therapeutics Inc. (Filer) CIK: 0001401040 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 424B2 | Act: 33 | File No.: 333-289542 | Film No.: 251242454
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)